Applied StemCell
As a leading cell and gene therapy contract research organization (CRO)/contract development and manufacturing organization (CDMO), Applied StemCell is a proud supporter of gene editing and stem cell therapy development. With two high-impact platforms, CRISPR/TARGATT™ genome editing and induced pluripotent stem cell (iPSC) (good manufacturing practice (GMP) grade), they seek to help advance the development of novel therapeutics. Along with their wide range of CRO service options, Applied StemCell provides GMP gene-editing and cell manufacturing services along with cell banking.
Latest Applied StemCell Content
Product
Advertisement
GMP & RUO Grade iPSC Gene Editing & Differentiation Services
Complete iPSC/MSC manufacturing platform: Generate, CRISPR engineer, and differentiate iPSCs into NK cells, T cells, neurons, or cardiomyocytes at Applied StemCell’s new GMP manufacturing facility in Milpitas, California.
Whitepaper
iPSCs To Accelerate Cell and Gene Product Development
These whitepapers highlight how optimized CRISPR protocols and site-specific knock-in technology can be used to engineer simple or complex genetic modifications in allogenic iPSCs.
Advertisement
